Davidson Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32	Closed	-$8.67K	–	85
2024 Q1	$8.67K	Buy	32 +4	+14%	+$955	﹤0.01%	69
2023 Q4	$6.62K	Hold	28	–	–	﹤0.01%	93
2023 Q3	$5.49K	Buy	28 +11	+65%	+$2.26K	﹤0.01%	61
2023 Q2	$3.58K	Buy	17 +1	+6%	+$199	﹤0.01%	80
2023 Q1	$3.23K	Buy	16 +3	+23%	+$680	﹤0.01%	81
2022 Q4	$2.83K	Sell	13 -51	-80%	-$11.1K	﹤0.01%	90
2022 Q3	$13K	Sell	64 -4,133	-98%	-$892K	0.01%	42
2022 Q2	$898K	Buy	4,197 +20	+0.5%	+$4.89K	0.42%	32
2022 Q1	$1.19M	Buy	4,177 +724	+21%	+$223K	0.44%	49
2021 Q4	$1.3M	Buy	3,453 +221	+7%	+$85.9K	0.71%	56
2021 Q3	$1.33M	Sell	3,232 -593	-16%	-$246K	0.67%	22
2021 Q2	$1.42M	Sell	3,825 -459	-11%	-$153K	0.68%	15
2021 Q1	$1.24M	Buy	4,284 +640	+18%	+$178K	0.65%	20
2020 Q4	$910K	Buy	3,644 +101	+3%	+$24.1K	0.51%	43
2020 Q3	$802K	Sell	3,543 -935	-21%	-$194K	0.51%	35
2020 Q2	$781K	Buy	4,478 +275	+7%	+$43.9K	0.69%	37
2020 Q1	$530K	Buy	+4,203	New	+$630K	0.76%	37